CMV has been called the 'neglected disease of the AIDS pandemic', in part because of limited access to treatment, especially in the developing world, where localised intra-ocular ganciclovir implants and systemic oral valganciclovir are unavailable or too costly.
What does VGC stand for?
VGC stands for Valganciclovir (antiviral agent)
This definition appears somewhat frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of VGC
We have 61 other meanings of VGC in our Acronym Attic
- Vista Grande Baptist Church (Colorado Springs, CO)
- variable graph blocking factor
- Västergötlands Bowlingförbund (Mariestad, Sweden)
- Vereinigung für Gefahrstoff und Brandschutzforschung
- Virtual Global Biodiversity Forum
- von Bertalanffy growth function
- Vserossiiskaya Gosudarstevennaya Biblioteka Inostrannoi Lituratura (Russia)
- Vermont Green Building Network
- Victorian Government Business Office (Australia)
- Valley Girl Barrel Racing Association
- Variable Geometry Chevron (Boeing)
- Vaughn Gross Center (Austin, TX)
- Vertical Gaze Center (ophthalmology)
- Vertical Granite Curb (roads; various locations)
- Very Good Condition
- Very Gravelly Clay (geology)
- Very Large Graph Class (also seen as VLGC)
- VG Cats (web comic)
- Victorian Garden Cottages (UK)
- Video Game Central (website)
Samples in periodicals archive:
Viral-associated trichodysplasia of immunosuppression: report of a pediatric patient with response to oral valganciclovir.
Fu Luan, MD, of the University of Michigan, Ann Arbor, and colleagues compared three months versus six months of treatment with the antiviral drug valganciclovir used to prevent CMV after kidney transplantation.
The study's results suggest that valganciclovir may be an effective and safe way to both prevent and treat these HHV-8-related diseases, he said at the annual meeting of the Infectious Diseases Society of America.
Drugs such as valaciclovir, valganciclovir, and captopril are known to be transported by PepT1.
Some examples include, but are not limited to, acyclovir, adefovir dipivoxil, cidofovir, ganciclovir, valacyclovir and valganciclovir.
Chimerix's presentation highlighted adverse effects (AEs) experienced by patients who received preemptive therapy and were treated with currently available antiviral agents, including valganciclovir, ganciclovir, foscarnet and cidofovir.
Treatment was changed to oral valganciclovir, 900 mg 2x/d for 20 days, upon discharge.